{"id":241989,"date":"2026-09-10T16:40:05","date_gmt":"2026-09-10T11:10:05","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=241989"},"modified":"2026-09-10T16:40:05","modified_gmt":"2026-09-10T11:10:05","slug":"injectables-stock-rises-76-percent-in-6-months","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/injectables-stock-rises-76-percent-in-6-months\/","title":{"rendered":"This Injectables Stock Rises 76% in 6 Months: What Is Behind the Sharp Rebound?"},"content":{"rendered":"

CMP Rs 2,946.90 (10 Sep 2026). 6-month return 76.06%. 52W range Rs 1,573.60 to Rs 3,042. Market cap Rs 49,901 Cr. Q1 FY27 PAT Rs 317 Cr, up 47%.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

Gland Pharma, a contract maker of sterile injectable medicines, is the injectables stock behind a return of approximately 76% in six months. The share climbed from a low of Rs 1,573.60 in March 2026 to near Rs 2,947 after profit nearly doubled in Q4 FY26 and rose 47% in Q1 FY27. The 5-year return is still negative and the share trades above the consensus analyst target.<\/p>\n<\/div>\n

This injectables stock has turned Rs 1 lakh into roughly Rs 1.76 lakh in just six months. One Hyderabad-based maker of sterile injectable medicines delivered a 6-month return of 76.06% as of 10 September 2026, ranking 13th in a screen of 101 large-cap and mid-cap NSE shares.<\/p>\n

The company is Gland Pharma Ltd<\/a> (NSE: GLAND)<\/strong>, one of India’s largest contract makers of injectable drugs for global pharma companies. The Gland Pharma share price climbed from around Rs 1,674 in early March 2026 to Rs 2,946.90 on 10 September 2026, taking its market value to approximately Rs 49,901 crore. This injectables stock rallied after two strong quarterly results in a row.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n